LBF20208PG01: Difference between revisions
No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
|LipidBank=XPR1771 | |LipidBank=XPR1771 | ||
|LipidMaps=LMFA03010101 | |LipidMaps=LMFA03010101 | ||
|SysName=9alpha,15S- | |SysName=(9alpha,15S) -Dihydroxy-11-oxo-prosta- (cis-5,trans-12) -dien-1-oic acid | ||
|Common Name=&&delta12-Prostaglandin D_2&&9alpha,15S- | |Common Name=&&delta12- Prostaglandin D_2&&(9alpha,15S) -Dihydroxy-11-oxo-prosta- (5Z,12E) -dien-1-oic acid&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Latest revision as of 08:52, 21 October 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1771 |
| LipidMaps | LMFA03010101 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20208PG01 |
| δ12- Prostaglandin D2 | |
|---|---|
| |
| Structural Information | |
| (9α,15S) -Dihydroxy-11-oxo-prosta- (cis-5,trans-12) -dien-1-oic acid | |
| |
| Formula | C20H32O5 |
| Exact Mass | 352.224974134 |
| Average Mass | 352.46508 |
| SMILES | C(CC[C@H](O)CC=C([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC |
| Physicochemical Information | |
| delta 12-PGD2 is catalyzed to delta 12-PGJ2, which has antimitotic and carcinogenic activities. Kato_T et al. Fukushima_M | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
